gyki 52466 has been researched along with diazepam in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (57.14) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hönack, D; Löscher, W | 1 |
Block, F; Schwarz, M | 1 |
Steppuhn, KG; Turski, L | 1 |
Allison, C; Gray, A; Pratt, JA | 1 |
Kontani, H; Ueda, Y | 1 |
Barkóczy, J; Bilkei-Gorzó, A; Gacsályi, I; Hársing, LG; Hegedus, E; Kapus, GL; Kompagne, H; Lévay, G; Leveleki, C; Vegh, M | 1 |
Fritsch, B; Joelle Donofrio, J; Rogawski, MA; Stott, JJ | 1 |
7 other study(ies) available for gyki 52466 and diazepam
Article | Year |
---|---|
Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil.
Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Diazepam; Dose-Response Relationship, Drug; Drug Interactions; Electroshock; Excitatory Amino Acid Antagonists; Flumazenil; Male; Mice; Muscle Relaxants, Central; Pentylenetetrazole; Quinoxalines; Receptors, AMPA; Reflex; Seizures; Synaptic Transmission | 1994 |
The depressant effect of GYKI 52466 on spinal reflex transmission in rats is mediated via non-NMDA and benzodiazepine receptors.
Topics: 2-Amino-5-phosphonovalerate; Amino Acids; Animals; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Depression, Chemical; Diazepam; Dose-Response Relationship, Drug; Electric Stimulation; H-Reflex; Injections, Spinal; Male; Quinoxalines; Rats; Rats, Wistar; Receptors, AMPA; Receptors, GABA-A; Receptors, N-Methyl-D-Aspartate; Reflex; Synaptic Transmission | 1994 |
Diazepam dependence prevented by glutamate antagonists.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Diazepam; Drug Tolerance; Electroencephalography; Electromyography; Excitatory Amino Acid Antagonists; Male; Mice; Mice, Inbred Strains; Motor Activity; Muscle Tonus; Piperazines; Quinoxalines; Seizures; Substance Withdrawal Syndrome; Substance-Related Disorders; Time Factors | 1993 |
A role for AMPA/kainate receptors in conditioned place preference induced by diazepam in the rat.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Conditioning, Psychological; Diazepam; Dose-Response Relationship, Drug; GABA Modulators; Male; Rats; Rats, Long-Evans; Receptors, AMPA; Receptors, Kainic Acid; Reward | 1999 |
A method for producing overactive bladder in the rat and investigation of the effects of GABAergic receptor agonists and glutamatergic receptor antagonists on the cystometrogram.
Topics: Animals; Baclofen; Benzodiazepines; Diazepam; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; GABA Modulators; Male; Rats; Rats, Sprague-Dawley; Urinary Incontinence | 2005 |
Antagonism of AMPA receptors produces anxiolytic-like behavior in rodents: effects of GYKI 52466 and its novel analogues.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Conflict, Psychological; Data Interpretation, Statistical; Diazepam; Electrophysiology; Excitatory Amino Acid Antagonists; Hippocampus; Male; Membrane Potentials; Mice; Motor Activity; Neurons; Patch-Clamp Techniques; Piperazines; Quinoxalines; Radioligand Assay; Rats; Rats, Wistar; Receptors, AMPA; Telencephalon | 2008 |
Treatment of early and late kainic acid-induced status epilepticus with the noncompetitive AMPA receptor antagonist GYKI 52466.
Topics: Animals; Anticonvulsants; Behavior, Animal; Benzodiazepines; Blood Pressure; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Electrodes, Implanted; Electroencephalography; Frontal Lobe; Kainic Acid; Male; Mice; Receptors, AMPA; Status Epilepticus | 2010 |